Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms’ tumor

Wilms’ tumor is the most common type of childhood kidney cancer. To improve risk stratification and identify novel therapeutic targets for patients with Wilms’ tumor, we used high-resolution mass spectrometry proteomics to identify urine tumor markers associated with Wilms’ tumor relapse. We determi...

詳細記述

保存先:
書誌詳細
出版年:JCI Insight
主要な著者: Ortiz, Michael V., Ahmed, Saima, Burns, Melissa, Henssen, Anton G., Hollmann, Travis J., MacArthur, Ian, Gunasekera, Shehana, Gaewsky, Lyvia, Bradwin, Gary, Ryan, Jeremy, Letai, Anthony, He, Ying, Naranjo, Arlene, Chi, Yueh-Yun, LaQuaglia, Michael, Heaton, Todd, Cifani, Paolo, Dome, Jeffrey S., Gadd, Samantha, Perlman, Elizabeth, Mullen, Elizabeth, Steen, Hanno, Kentsis, Alex
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Clinical Investigation 2019
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693841/
https://ncbi.nlm.nih.gov/pubmed/31391345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.127098
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料